Company: BNBX
Filing Date: 2025-02-13
Form Type: 10-Q
Source: 0001410578-25-000126
Chunk: 10

Company: BNB PLUS CORP.
Filing Date: 2025-02-13
Form: 10-Q
Item: Part II, Item 6E
Chunk 10
---
Item 6. — Exhibits.

​​​​​​​​​​​​​​​​Incorporated by Reference to SEC Filing​Filed or Furnished withExhibit​​​​​Exhibit​​​​​this FormNo.    Filed Exhibit Description    Form    No.    File No.    Date Filed    10-Q3.1​Conformed version of Certificate of Incorporation of Applied DNA Sciences, Inc., as most recently amended by the Sixth Certificate of Amendment, effective Thursday, April 25, 2024​1​3.1​333-278890​05/15/2024​​3.2​Conformed version of By-Laws, as amended by the Certificate of Amendment to the By-laws, effective November 7, 2024​S-1​3.2​333-283315​11/19/2024​​4.1​Form of Pre-Funded Warrant​8-K​4.1​001-36745​10/30/2024​​4.2​Form of Series C Common Stock Purchase Warrant​8-K​4.2​001-36745​10/30/2024​​4.3​Form of Series D Common Stock Purchase Warrant​8-K​4.3​001-36745​10/30/2024​​4.4​Form of Placement Agent Warrant​8-K​4.4​001-36745​10/30/2024​​10.1​Form of Securities Purchase Agreement, dated October 30, 2024, by and between Applied DNA Sciences, Inc. and the parties thereto​8-K​10.1​001-36745​10/30/2024​10.2​Form of Warrant Amendment​8-K​10.2​001-36745​10/30/2024​​10.3​Waiver of Negative Covenant​8-K​10.3​001-36745​10/30/2024​​31.1**​Certification of Chief Executive Officer, pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002​​​​​​​​​X31.2**​Certification of Chief Financial Officer, pursuant to Rules 13a-14